Is Philip Morris Stock Overvalued?
If there is one industry that can be termed truly…
Buy
54
THC Quote, Financials, Valuation and Earnings
Last price:
$134.56
Seasonality move
:
7.03%
Day range:
$131.17 - $134.91
52-week range:
$79.00 - $171.20
Dividend yield:
0%
P/E ratio:
4.31x
P/S ratio:
0.64x
P/B ratio:
3.33x
Volume:
1.1M
Avg. volume:
1.3M
1-year change:
63.6%
Market cap:
$12.8B
Revenue:
$20.5B
EPS (TTM):
$31.21
Analysts' Opinion
-
Consensus RatingTenet Healthcare has received a consensus rating of Buy. The company's average rating is a Buy based on 11 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $177.96, Tenet Healthcare has an estimated upside of 32.38% from its current price of $134.43.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $140.00 representing 100% downside risk from its current price of $134.43.
Fair Value
-
According to the consensus of 15 analysts, Tenet Healthcare has 32.38% upside to fair value with a price target of $177.96 per share.
THC vs. S&P 500
-
Over the past 5 trading days, Tenet Healthcare has overperformed the S&P 500 by 2.07% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Tenet Healthcare does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Tenet Healthcare has grown year-over-year revenues for 8 quarters straight. In the most recent quarter Tenet Healthcare reported revenues of $5.1B.
Earnings Growth
-
Tenet Healthcare has grown year-over-year earnings for 4 quarters straight. In the most recent quarter Tenet Healthcare reported earnings per share of $4.89.
Enterprise value:
25.8B
EV / Invested capital:
--
Price / LTM sales:
0.64x
EV / EBIT:
4.33x
EV / Revenue:
1.23x
PEG ratio (5yr expected):
0.01x
EV / Free cash flow:
10.78x
Price / Operating cash flow:
5.62x
Enterprise value / EBITDA:
3.79x
Gross Profit (TTM):
$17.3B
Return On Assets:
10.9%
Net Income Margin (TTM):
14.91%
Return On Equity:
45.56%
Return On Invested Capital:
15.18%
Operating Margin:
13.8%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $19B | $20.2B | $21B | $5.1B | $5.1B | |
| Gross Profit | $15.8B | $16.6B | $17.3B | $4.2B | $4.2B | |
| Operating Income | $2.5B | $2.3B | $2.9B | $579M | $707M | |
| EBITDA | $3.3B | $3.2B | $6.8B | $796M | $1.3B | |
| Diluted EPS | $5.08 | $4.33 | $31.21 | $0.94 | $4.89 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $7.8B | $6.9B | $6B | $6.4B | $8.8B | |
| Total Assets | $26.2B | $25.9B | $27.1B | $27.6B | $29.4B | |
| Current Liabilities | $5.8B | $5.4B | $4.3B | $4.4B | $5.5B | |
| Total Liabilities | $24.2B | $22.2B | $22.5B | $22.4B | $21.3B | |
| Total Equity | $2B | $3.7B | $4.6B | $5.2B | $8.1B | |
| Total Debt | $15.7B | $14.1B | $15.1B | $15B | $12.9B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1B | $2B | $3.2B | $503M | $1B | |
| Cash From Investing | -$2B | -$942M | $3.5B | -$169M | $667M | |
| Cash From Financing | -$85M | -$1.2B | -$3.6B | -$214M | -$498M | |
| Free Cash Flow | $243M | $1.1B | $2.4B | $327M | $829M | |
THC
Sector
Market Cap
$12.8B
$45.7M
Price % of 52-Week High
78.52%
47.48%
Dividend Yield
0%
0%
Shareholder Yield
7.7%
-0.75%
1-Year Price Total Return
63.6%
-32.34%
Beta (5-Year)
2.065
0.746
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$130.40
200-day SMA
Sell
Level
$139.78
Bollinger Bands (100)
Sell
Level
135.48 - 163.66
Chaikin Money Flow
Sell
Level
-261.3M
20-day SMA
Buy
Level
$128.38
Relative Strength Index (RSI14)
Buy
Level
53.96
ADX Line
Buy
Level
16.35
Williams %R
Sell
Level
-3.338
50-day SMA
Sell
Level
$139.72
MACD (12, 26)
Sell
Level
-1.75
25-day Aroon Oscillator
Sell
Level
-56
On Balance Volume
Sell
Level
-250.3M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.3105)
Sell
CA Score
(Annual)
Level (-1.8331)
Buy
Beneish M-Score
(Annual)
Level (-2.657)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (0.6606)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Tenet Healthcare is a Dallas-based healthcare services organization. It operates a collection of hospitals (about 50 as of July 2024) and over 500 ambulatory surgery centers and other outpatient facilities across the U.S., primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
Stock Forecast FAQ
In the current month, THC has received 11 Buy ratings 4 Hold ratings, and 0 Sell ratings. The THC average analyst price target in the past 3 months is $177.96.
-
Where Will Tenet Healthcare Stock Be In 1 Year?
According to analysts, the consensus estimate is that Tenet Healthcare share price will rise to $177.96 per share over the next 12 months.
-
What Do Analysts Say About Tenet Healthcare?
Analysts are divided on their view about Tenet Healthcare share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Tenet Healthcare is a Sell and believe this share price will drop from its current level to $140.00.
-
What Is Tenet Healthcare's Price Target?
The price target for Tenet Healthcare over the next 1-year time period is forecast to be $177.96 according to 15 Wall Street analysts, 11 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is THC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Tenet Healthcare is a Buy. 11 of 15 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of THC?
You can purchase shares of Tenet Healthcare via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Tenet Healthcare shares.
-
What Is The Tenet Healthcare Share Price Today?
Tenet Healthcare was last trading at $134.56 per share. This represents the most recent stock quote for Tenet Healthcare. Yesterday, Tenet Healthcare closed at $134.43 per share.
-
How To Buy Tenet Healthcare Stock Online?
In order to purchase Tenet Healthcare stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
What Quantum Stocks Should I Buy?
The last several years have seen a series of tech…
Will Sirius XM Be a 10-Bagger Stock?
Last year, Warren Buffett surprised practically everyone when he acquired…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
49
RKLB alert for Jan 22
Rocket Lab USA [RKLB] is down 5.95% over the past day.
Sell
32
FTAI alert for Jan 22
FTAI Aviation [FTAI] is down 0.95% over the past day.
Sell
2
EDU alert for Jan 22
New Oriental Education & Technology Group [EDU] is down 3% over the past day.
